AbCellera Biologics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Revenue	28.83	38.03	485.42	375.2	233.16	Upgrade
Revenue Growth (YoY)	-24.17%	-92.17%	29.38%	60.92%	1907.88%	Upgrade
Cost of Revenue	167.26	175.66	174.32	107.58	56.54	Upgrade
Gross Profit	-138.43	-137.63	311.11	267.63	176.62	Upgrade
Selling, General & Admin	85.49	75.18	66.76	48.76	15.75	Upgrade
Operating Expenses	144.34	99.57	86.2	63.21	20.59	Upgrade
Operating Income	-282.77	-237.21	224.91	204.41	156.03	Upgrade
Interest Expense	-	-	-	-	-6.81	Upgrade
Interest & Investment Income	38.47	42.25	16.08	3.33	0.29	Upgrade
Other Non Operating Income (Expenses)	11.2	13.1	8.21	11.91	8.32	Upgrade
EBT Excluding Unusual Items	-233.1	-181.86	249.2	219.65	157.83	Upgrade
Gain (Loss) on Sale of Investments	17.4	3.9	-1.7	-0.5	-	Upgrade
Asset Writedown	-32	-	-8.4	-	-	Upgrade
Other Unusual Items	47.3	3.93	-	-	-	Upgrade
Pretax Income	-200.4	-174.03	239.1	219.15	157.83	Upgrade
Income Tax Expense	-37.54	-27.63	80.58	65.69	38.92	Upgrade
Net Income	-162.86	-146.4	158.52	153.46	118.92	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	33.82	Upgrade
Net Income to Common	-162.86	-146.4	158.52	153.46	85.1	Upgrade
Net Income Growth	-	-	3.29%	29.05%	-	Upgrade
Shares Outstanding (Basic)	294	289	285	276	159	Upgrade
Shares Outstanding (Diluted)	294	289	315	318	263	Upgrade
Shares Change (YoY)	1.79%	-8.15%	-1.09%	20.96%	73.88%	Upgrade
EPS (Basic)	-0.55	-0.51	0.56	0.56	0.53	Upgrade
EPS (Diluted)	-0.55	-0.51	0.50	0.48	0.45	Upgrade
EPS Growth	-	-	4.17%	6.21%	-	Upgrade
Free Cash Flow	-186.95	-120.82	206.7	186.13	13.02	Upgrade
Free Cash Flow Per Share	-0.64	-0.42	0.66	0.58	0.05	Upgrade
Gross Margin	-	-	64.09%	71.33%	75.75%	Upgrade
Operating Margin	-980.70%	-623.82%	46.33%	54.48%	66.92%	Upgrade
Profit Margin	-564.83%	-385.00%	32.66%	40.90%	36.50%	Upgrade
Free Cash Flow Margin	-648.40%	-317.75%	42.58%	49.61%	5.58%	Upgrade
EBITDA	-223.92	-212.81	244.35	218.88	160.87	Upgrade
EBITDA Margin	-	-	50.34%	58.34%	69.00%	Upgrade
D&A For EBITDA	58.85	24.4	19.44	14.47	4.84	Upgrade
EBIT	-282.77	-237.21	224.91	204.41	156.03	Upgrade
EBIT Margin	-	-	46.33%	54.48%	66.92%	Upgrade
Effective Tax Rate	-	-	33.70%	29.97%	24.66%	Upgrade
Revenue as Reported	28.83	38.03	485.42	375.2	233.16	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q